
Daniel Flora, MD, PharmD, is a hematologist and medical oncologist at St. Elizabeth Healthcare, where he serves as Medical Director of Oncology Research and leads the Phase I clinical trials program. His clinical work focuses on melanoma and breast cancer, with an emphasis on integrating cutting-edge therapeutics with thoughtful, patient-centered care. He is particularly interested in integrative oncology, combining evidence-based lifestyle, metabolic, and exercise strategies with modern cancer treatment. Dr. Flora’s research centers on precision therapeutics and clinical pharmacology to individualize treatment and reduce toxicity, alongside the development of novel targeted and immune-based therapies. His work also explores how AI-enabled tools can expand access to clinical trials, improve patient navigation, and modernize how oncology care is delivered. He has been recognized with the Arnold P. Gold Foundation Humanism in Medicine Award, the Cancer Family Care Unsung Heroes Award, and Top Doctor honors, and has served in national advisory roles in oncology research. He holds dual doctorates as both an MD and a PharmD.
Attending Physician
2014 – present
Medical School
2004 – 2008
Residency
2008 – 2011
Fellowship
2011 – 2014